News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...